评估介质干细胞作为遗传视网膜疾病的体外模型
Maria Dodina1, Dzerassa Gurtsieva1, Alexander Karabelsky1
1Sirius University of Science and Technology, Krasnodar, Russia.
Frontiers in cell and developmental biology
|December 2, 2024
概括
介质细胞干细胞 (MSC) 提供了一种具有成本效益和快速的方法,用于创建视网膜遗传疾病 (IRD) 的体外模型. 这些模型有助于了解疾病病理学和查药物,补充了传统的动物研究.
科学领域:
- 眼科和再生医学眼科和再生医学
- 干细胞生物学 干细胞生物学
- 遗传学和疾病建模学
背景情况:
- 遗传性视网膜疾病 (IRD) 会导致明显的视力损伤和失明.
- 在体外模型对于理解IRD开发和查治疗方法至关重要.
- 目前的体外模型面临的局限性,包括成本,时间和精确的人类表型复制.
研究的目的:
- 审查细胞类型用于体外遗传性视网膜疾病 (IRD) 建模.
- 突出介质干细胞 (MSCs) 作为IRD建模的有前途平台.
- 讨论分化方法,并将MSC与诸如诱导多能干细胞 (iPSC) 等其他细胞来源进行比较.
主要方法:
- 对遗传性视网膜疾病的体外模型现有文献的综述.
- 分析各种细胞来源,包括细胞系,原细胞,iPSC和MSC.
- 对MSCs进入视网膜细胞 (光受体,RPE) 的分化协议的检查.
主要成果:
- 介酶干细胞 (MSC) 可以从各种来源 (骨髓,脂肪组织等) 中分离出来. 然后分化为视网膜细胞.
- 差异化方法包括诱导介质,共同培养和基因调节 (TFs,miRNAs).
- 基于MSC的模型比iPSC模型更便宜,更快速生成,从而促进大规模的药物查.
结论:
- 介质细胞干细胞 (MSC) 为开发遗传视网膜疾病 (IRD) 的体外模型提供了可行且具有成本效益的替代方案.
- 需要进一步优化差异化协议,才能充分发挥基于MSC的IRD模型的潜力.
- 在临床前研究中,MSC模型为了解IRD和加速治疗开发提供了优势.
更多相关视频
相关概念视频
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


